Ambulero Raises Up To $5.5 Million from Orphinic Scientific
Ambulero Raises Up To $5.5 Million from Orphinic Scientific Miami Cell and Gene Therapy Company Opens European Subsidiary To Advance Gene Therapy For Rare Vascular Disease January 25, 2021 21:46 ET | Source: Ambulero Ambulero Miami, Florida, UNITED STATES MIAMI, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease, today announce...
Source: globenewswire.com